Are Cable Companies Secretly Planning An "A La Carte" Option? [Television]

According to Reuters, cable companies are secretly discussing plans that'll let customers choose what channels they want. Content providers won't like this "a la carte" arrangement, but who cares. This is something customers wanted like yesterday. [Reuters via Tech Crunch; Image from IKO/Shutterstock] More »

Source: http://feeds.gawker.com/~r/gizmodo/full/~3/eeF6cp1kDxA/are-cable-companies-secretly-planning-an-a-la-carte-option

tony romo washington monument demarcus ware terra nova dallas cowboys ellen degeneres miles austin

Who's Investing in Commodities? | Futures, Commodities

The easiest answer for this question is: anyone who doesn?t mind being in a riskier market. In fact, the commodities market is reputed to be so volatile that fortunes can be made or lost in a matter of minutes or hours, if you do not know what you?re doing. To get a better understanding of investing in the commodities market, let us take a look at some of the basics.

What is a commodity?

A commodity is anything that can be bought or sold. Examples of a commodity can include oil, gold, oranges and currency. When you invest in commodities, you?re basically betting on what the market will do. You?ll bet that the price of oranges will rise or that the value of the dollar will fall.

Investment strategies in commodities

The next insightful element with reference to this subject matter. Most financial experts don?t recommend investing anything in the commodities market that you can not afford to lose. It?s not the investment type for someone who wishes for a safe investment for their retirement account, unless you put your money into a managed account.

Just Launched Silver Coin Reserve Best-Investment-Strategy-For-2010 ? YouTube

But nevertheless, if you don?t mind higher risk in return for the greater chance of higher returns, commodities might be a good option. Commodities are a great way to use a portion of your portfolio in higher risk/higher return investment, but should never be used as a major segment of your portfolio.

Safe investing in commodities

If you really want to take your turn at commodities investment, but want to minimize your risk, take a look at commodities funds. Because these funds include a mixture of different commodities, the risk may be minimized by the very nature of the portfolio.

If it?s riskier, why would anyone invest in commodities?

The return, when someone wins in the market, can be extremely high. There have been a number of millionaires made through commodities trading and will do so again in the future.

At the same time, it has long been understood that the commodities market is a great hedge against inflation. When inflation unexpectedly hits, the commodities funds tend to do a lot better.

As a final point, commodities are always in demand. Gold, oil and currency will always have a market because we need them. They?ll never become outdated and the demand will never disappear.

Investing in commodities may be the perfect investment for anyone who does not mind using a small portion of their portfolio in higher risk activities in order to achieve a higher reward. If you don?t have the time to follow markets and industries on a day to day or hour to hour basis, checking out the commodities funds are the next best thing.

Caterina Christakos is an experienced investor and instructor with World Capital Institute. Ever imagined an exciting career as a stock or commodities broker. Make the dream a reality here: [http://www.worldcapitalinstitute.com]

Source: http://i-commoditiesfutures.com/whos-investing-in-commodities/

baklava msp 101 101 atlantic city scrabble word finder minoxidil

No console required: Online next-gen gaming system launches in ...

OnLive, a new online gaming system that gives users access to next-generation games via the internet with no need for a console, has gone live in the UK. Gamers can play around 150 games, including high-profile titles such as Assassins Creed and Deus Ex, on various devices including PCs, Mac tablets and net-connected televisions. There is no charge for the actual OnLive software, users can sign up and download it for free.

Gamers can play around 150 games, including high-profile titles such as Assassins Creed and Deus Ex, on various devices including PCs, Mac tablets and net-connected televisions.

There is no charge for the actual OnLive software, users can sign up and download it for free.

However, a ?micro-console? is a separate piece of hardware that can be used with regular TVs and can be bought from GAME and Gamestation for a retail price of ?69.99.

Games can be rented for 3 or 5 days, or gamers can opt to buy a ?full pass?. Additionally, OnLive offer a subscription service called ?PlayPack?, which allows subscribers to access a catalogue of over 100 games ? this costs ?6.99 per month.

PlayPack subs also benefit from a 30% discount off all normal prices.

The cloud-based system was launched at the Eurogamer Expo at Earls Court, west London, where around 40,000 enthusiasts will gather over the next few days to try out the latest games.
OnLive works in partnership with communications giant BT in the Uk, and customers of BT will be able to enjoy gaming for free, as BT Total and BT Infinity customers will get three months free, resulting in a saving of over ?20.

Whilst officials admit that the picture quality will not be as good as games consoles and or a game from a high-spec PC, they have added that the on demand feature and the sheer choice of games is what makes the service so popular.

OnLive pioneer cloud gaming. While games on similar services such as XBLA, PSN and Steam have to be downloaded and stored on a hard drive, OnLive games exist on an external server where all the processing is done. All that?s handled at the player?s end is a video stream, meaning that high-spec games can be played on relatively low-end hardware.

Steve Perlman, OnLive Founder and CEO, said: ?OnLive is incredibly excited to bring instant-play, on-demand cloud gaming to the UK. OnLive is an entirely new way of experiencing top-tier video games, anywhere, anytime and on virtually any connected device, whether TV, PC, Mac or tablet, with awesome cloud-powered features and community unlike anything you?ve ever seen before. UK gamers, welcome to OnLive!?

John Spinale, OnLive VP of Games and Media, stated: ?We?re excited to bring an incredible range of social features to the UK that are unique to the OnLive world. OnLive UK gamers will immediately find themselves immersed in OnLive?s international massive spectating and voice chat community, which adds an unprecedented dimension to the gaming experience.?

Source: http://www.digitalstrategyconsulting.com/intelligence/2011/09/no_console_required_online_nex.php

asn dukan diet mark sanchez faith hill non hodgkin lymphoma lymphoma ciara

school grants tips by Schoolgrantsguru - Recipe - Tasty Planner

This has led to a shortfall of dentists in the region leading to higher dental care charges charged by the current dentists. To cover their educational fees, numerous students count on dental school grants as they do not need to be repaid. Some of the dental school grants accessible are offered below.Johnson & Johnson GrantsJohnson and Johnson along with the support of American Dental Affiliation provide dental college grants to pupils with academic excellence and learning preventive dentistry. This grant assigns $2500 for tuition and fees for twelve pupils each and every year. The dental students can utilize for three students each year with outstanding educational report.American Academy of PeriodontologyAny university student enrolled in the 3rd year of a graduate periodontal system at a regarded college or college could be qualified for the Dr. and Mrs. Gerald M. Kramer College Award for Excellence. The grant awards $10,000 to qualified pupils.As demands to the software process, a letter of reference from the chairperson of the plan should be supplied. Also, two other letters of reference from faculty members, two letters of reference from private contacts must also be provided.American Dental Association BasisOther scholarships to students enrolled in dentistry, dental assisting, dental hygiene and dental laboratory technologies might also be accessible by American Dental Affiliation. Scholarship money that is granted to the university student may possibly depend on the plan and the applicant.Academy of LDS DentistsDental pupils that are a member of the Church of Latter Day Saints may also be eligible for grant funds ranging from $one thousand to $1500 from the Academy of LDS Dentists. The essential specifications are the completion of at least one 12 months of the dental plan and a membership to the Academy of LDS Dentists.The previously mentioned stated are a couple of dental school grants accessible to prospective dental students, nonetheless, many other dental school grants and scholarships are also accessible.All university college students should know the details about college grants as effectively as economic support in common. In quick, fiscal assist is a thing that just about each and every school university student is likely to require at some level for the duration of their career as a university student. In certain, grant funds has actually aided a lot of college students above the decades to pay for university tuition. Without having grant money there would be a good many men and women out there that would have missed out on heading to university due to the fact of finances. All that stated finding out about grants is not that hard. In reality, the essentials can be grasped in just a matter of minutes.The initial thing that you need to have to realize about grant funds is that it is entirely free. When you use grant cash to pay out for your college you will by no means have to pay it back again. This is why grants are so common. If most college students had the expertise they would seek more grants out as opposed to taking out loans. By studying about the facts in regard to grants you will be certain not to miss out on any of the possibilities that you might have for the totally free funds. http://cherri-blossoms.com/education/study-can-be-much-more-interesting-by-school-grants , http://netbeansboy.com/education/to-finish-your-children-study-can-be-help-by-using-school-grants , http://cookooo.com/education/the-perfect-things-if-you-get-the-school-grants

Recipe Source: Garrett

Source: http://tastyplanner.com/recipes/school-grants-tips

osu 9 11 conspiracy theories 9 11 conspiracy theories zeitgeist bush ellie goulding ginger

BIBF 1120* in patients with metastatic colorectal cancer as effective ...

Results from a Phase I/II study among the few to have been selected for presentation in the Presidential Session at the 2011 European Multidisciplinary Cancer Congress (EMCC).

STOCKHOLM - Tuesday, September 27th 2011 [ME NewsWire]

(BUSINESS WIRE)? FOR NON-US MEDIA ONLY

Patients with metastatic colorectal cancer (mCRC) receiving BIBF 1120* as first-line treatment in combination with mFOLFOX6 showed a median progression-free survival of 10.6 months which was equivalent to bevacizumab plus mFOLFOX6 in a randomised two arm phase II study enrolling a total of 126 patients. Importantly, only 34.1% of those patients taking BIBF 1120* experienced any kind of serious adverse events, versus 53.7% of those taking bevacizumab.

More detailed results from the trial are:

The objective response rate (ORR), a measure of tumour shrinkage, was 61.2% in the BIBF 1120* arm and 53.7% in the bevacizumab arm.
Patients receiving BIBF 1120* had a similar progression-free survival rate at 9 months to those taking bevacizumab (63% vs. 69%).
Importantly, patients on BIBF 1120* experienced a lower frequency of serious gastrointestinal adverse events than those receiving bevacizumab (11.8% vs. 29.3%).

The study is ongoing in order to collect overall survival data. Phase III trials with larger patient populations will be considered to confirm these positive results and to further investigate the potential of BIBF 1120* in mCRC.

Unlike other angiokinase inhibitors which only target one receptor, BIBF 1120* is a novel triple angiokinase inhibitor that blocks three growth factor receptors simultaneously (VEGFR 1-3, PDGFR alpha and beta and FGFR 1-3).1 All three receptor types play a critical role in the formation and maintenance of new blood vessels (angiogenesis).Their blockade may lead to the inhibition of angiogenesis, and may ultimately stop tumour growth and spread.2, 3

?These new study results hold promise for further investigation of BIBF 1120* in patients suffering from advanced colorectal carcinoma,? said Prof Eric Van Cutsem, lead investigator for the trial, and Professor of Internal Medicine at the University of Leuven, Belgium. ?It is utterly important to provide therapeutic options to our patients with less serious treatment complications, which is particularly significant as these patients have advanced disease. I would very much look forward to seeing further results to confirm the potential of BIBF 1120* in this patient population.?

*BIBF 1120* has also demonstrated potential in other cancer types, and is currently in phase III development in lung and ovarian cancer.

Notes to editors

Abstract presentation details Abstract title: LATE BREAKING ABSTRACT: A Phase I/II, Open-label, Randomised Study of BIBF 1120* Plus mFOLFOX6 Compared to Bevacizumab Plus mFOLFOX6 in Patients with Metastatic Colorectal Cancer Abstract number: 14LBA Speaker LBA: Van Cutsem, E. (B) Session being presented: Presidential Session IV: Best and Late Breaking Abstracts Location: Hall A1 Date: 27-Sep-2011 Time: 09:00-11:00

About Trial Nr. NCT 00904839 The primary objective of this Phase I/II study was to evaluate progression free survival (PFS) rate at 9 months of patients receiving BIBF 1120 in combination with mFOLFOX6 compared to patients receiving bevacizumab combined with mFOLFOX6 in first line metastatic colorectal cancer. PFS rate was defined as the percentage of patients whose disease did not progress 9 months after the treatment had started.

About Colorectal Cancer Colorectal cancer is the second most common cause of death from cancer across all cancer types in men and women in Europe4, and is the third most commonly reported cancer in the world, with over one million cases occurring annually.5

About Boehringer Ingelheim in Oncology Building on scientific expertise and excellence in the fields of pulmonary and cardiovascular medicine, metabolic disease, neurology, virology and immunology, Boehringer Ingelheim has embarked on a major research programme to develop innovative cancer drugs. Working in close collaboration with the international scientific community and a number of the world?s leading cancer centres, Boehringer Ingelheim?s commitment to oncology is underpinned by using advances in science to develop a range of targeted therapies for various solid tumours and haematological cancers.

The current focus of research includes compounds in three areas: angiogenesis inhibition, signal transduction inhibition and cell-cycle kinase inhibition. BIBF 1120* is currently in phase III clinical development in NSCLC and further solid cancer types. Afatinib* is currently in phase III clinical development in NSCLC and breast cancer. In the area of cell-cycle kinase inhibition, Boehringer Ingelheim is developing an inhibitor of polo-like kinase 1 (Plk1), volasertib*, a protein that is involved in the processes of cell division.

Boehringer Ingelheim?s oncology pipeline is evolving and demonstrates the company?s continued commitment to the disease area.

* Afatinib, BIBF 1120 and volasertib are investigational compounds. Their safety and efficacy have not yet been fully established.

Boehringer Ingelheim The Boehringer Ingelheim group is one of the world?s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 145 affiliates and more than 42,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.

As a central element of its culture, Boehringer Ingelheim pledges to act socially responsible. Involvement in social projects, caring for employees and their families, and providing equal opportunities for all employees form the foundation of the global operations. Mutual cooperation and respect, as well as environmental protection and sustainability are intrinsic factors in all of Boehringer Ingelheim?s endeavours.

In 2010, Boehringer Ingelheim posted net sales of about 12.6 billion Euro while spending almost 24% of net sales in its largest business segment Prescription Medicines on research and development.

For more information please visit:

www.boehringer-ingelheim.comor www.thewhiteroom.info

References

1.Hilberg F et al. BIBF1120: Triple angiokinase inhibitor with sustained receptor blockade and good anti-tumor efficacy. Cancer Research 2008;68(12): 4774-4782.

2.Folkman N. Clinical Applications of Research on Angiogenesis. New England Journal of Medicine 1995;333: 1757-1763.

3.Ellis, L.M. and Hicklin, D.J. VEGF-targeted therapy: mechanisms of anti-tumour activity. Nature Reviews Cancer 2008;8: 579-591.

4.Ferlay J et al. Estimates of cancer incidence and mortality in Europe in 2008. Int J Cancer 2010;46: 765-781.

5.Ferlay J et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.Int J Cancer 2010; EPub Ahead of print.

Contacts

Boehringer Ingelheim GmbH

Corporate / Global Media Contact

Dr. Heike Specht

Tel.: +49 (6132) 77-93319

E-mail: heike_1.specht@boehringer-ingelheim.com

Source: http://pressrelease.smartarabs.com/?p=2751

jennifer garner jennifer garner yelp dominique strauss kahn kate winslet deus ex human revolution deus ex

G20 pledge offers respite for shares, euro (Reuters)

LONDON (Reuters) ? European shares inched up from 26-month lows on Friday and the euro rose after the G20 major economies pledged to preserve financial stability, but risk sentiment remained fragile on fears of renewed recession in the developed world.

Finance ministers and central bankers from the Group of 20 said they would take "all steps necessary" to calm the global financial system and said central banks were ready to provide liquidity, helping the euro advance against the dollar.

The G20 pledge of action provided a respite for world stocks after they tumbled to their lowest level in 13 months on Thursday, hurt by the risk of new recessions in the United States and Europe and weaker economic data from China.

Metals prices bucked the trend, falling on worries that the gloomy economic outlook signaled lower industrial demand, and analysts said any G20-inspired market bounce would likely be short-lived.

The pan-European FTSEurofirst 300 index rose 0.4 percent, after dropping 4.7 percent on Thursday.

"It is a relief rally and investors are just picking up some stocks on the cheap," Mark Priest, senior trader at ETX Capital said.

"I do not see how everything has changed overnight. Kick-starting the economy is easier said than done and it will take a lot more than what has been put on the table."

The tentative gains in Europe contrasted with falls in Asia, where the MSCI's broadest index of Asia Pacific shares outside Japan fell 3 percent to its lowest level since May 2010. This pulled the MSCI world equity index 0.1 percent down.

The G20 statement came as finance ministers and central bankers met in Washington, under pressure from investors to show action in the face of rising stresses in the financial system.

Several European banks have seen their share prices tumble and their cost of funding rise as investors worried about their exposure to debt issued by Greece and other debt-heavy euro zone countries.

Global stocks as measured by MSCI's All-Country World index are now in bear market territory -- defined as a fall of 20 percent or more -- having fallen 23 percent from their 2011 high in May.

The euro clawed off an 8-month low against the dollar and was last up 0.4 percent up at $1.3511 after the G20 pledge and as the tentative recovery in riskier assets prompted some profit-taking in the dollar.

The G20 also said the euro zone's rescue fund could be bolstered but traders and strategists said there was little that was new and the pledges needed to be followed up with action.

"I think there was some expectation in the market that they would signal concrete action or immediate coordinated steps but that language of their statement sticks very much to what we've heard from them in the past," said Todd Elmer, a currency strategist at Citi in Singapore.

"I wouldn't be surprised to see the slight bounce we have seen in the euro and other risky assets this morning start to unwind," he added.

Commodity markets, copper in particular, bore the brunt of the global rout that accompanied the Fed's gloomy outlook. Brent crude oil futures posted their biggest single-day loss in six weeks on Thursday and the Reuters-Jefferies CRB commodity index lost 4.4 percent.

Metals fell further on Friday, with copper losing 7 percent to $7,140 a metric ton, nickel down more than 8 percent and tin plunging more than 12 percent.

Brent futures were slightly firmer at $105.72 a barrel.

(Additional reporting by Alex Richardson and Masayuki Kitano in Singapore, Atul Prakash in London; Editing by John Stonestreet)

Source: http://us.rd.yahoo.com/dailynews/rss/eurobiz/*http%3A//news.yahoo.com/s/nm/20110923/bs_nm/us_markets_global

joe cole joe cole inkling lille lille lakeland lakeland

China's manufacturing slows as U.S., Europe stall (Reuters)

BEIJING (Reuters) ? China's manufacturing sector contracted for a third consecutive month in September while a measure of inflation picked up, suggesting the world's No.2 economy may not be able to provide much of a counterweight to flagging U.S. and European growth.

HSBC's China Flash Purchasing Managers' Index, designed to give an early snapshot of the month's factory activity, dipped to 49.4 from August's final figure of 49.9. A reading below 50 indicates contraction.

Economists and Chinese officials have widely predicted China's growth will slow, largely because of waning exports. The country, known as the factory to the world, is especially vulnerable to fading demand from the United States and Europe, its two biggest export markets.

"The exports sector looks increasingly at risk given the shaky global fundamentals," said Connie Tse, an economist at FORECAST in Singapore.

While prospects dim abroad, demand has held up well at home. That should keep China's economic growth securely above 8 percent, the level that many economists see as the minimum required to generate enough jobs for the country's rapidly urbanizing population.

"Fears of a hard landing are unwarranted," said Qu Hongbin, China economist at HSBC.

However, that resilient domestic demand is also keeping inflation elevated. Thursday's data showed input costs rising rapidly, which could handcuff China's central bank.

Back in 2008, when the global economy tipped into a deep recession, China's quick policy response was credited with helping to hasten the worldwide recovery. As long as inflation is high, Beijing will be less inclined to repeat that feat.

Hong Kong's Hang Seng Index added to losses after the PMI figures were released, down more than 4 percent at 0515 GMT. Asia's markets were already on the back foot after the Federal Reserve warned of "significant" risks to the U.S. economy, and the weak Chinese data only worsened the mood.

A similar set of data for the euro zone, due later on Thursday, is expected to show the PMI dipped to 48.5 from August's 49.0, according to a Reuters poll of economists.

'SLUGFLATION' STRIKES

With growth near stall speed in both the United States and Europe, it is no surprise that China's export-led economy is slowing. Its exports pulled back from a record high in August.

The PMI figures pointed to further slowing ahead. Both the new orders and new export orders sub-indices fell further below the 50-point mark in September.

But rising inflation pressures pose a policy dilemma for the People's Bank of China. Many economists think the PBOC will pause in its year-long tightening campaign to see how the global turmoil plays out.

The PMI data showed the input price sub-index rose to 58.8 in September, a four-month high. If manufacturers are paying more to produce goods, those higher costs could filter into consumer prices, driving up the inflation rate.

That would leave the PBOC in a bind. Premier Wen Jiabao and other leaders have repeatedly stressed that cooling inflation remains the top policy priority.

"You're between a rock and a hard place here," Jim Walker, founder of Asianomics, said in a Reuters Insider interview. "If you try to control the inflation, the growth gets worse. If you try to increase the growth, the inflation gets worse."

China's central bank has raised interest rates five times and lifted banks' reserve requirements nine times since October. The consumer price index eased to 6.2 percent last month, pulling back slightly from a three-year high notched in July, but it remains well above China's 4 percent target.

DIVIDED G20

The global economy could use every bit of growth that China can generate. It is one of the few countries with both the capacity to ease policy and the size to make it matter.

Interest rates are already at or near record lows in the United States, Japan and Europe. All three regions carry heavy debt burdens that make it financially and politically difficult for them to provide more fiscal stimulus.

This will no doubt be a big topic of discussion among the Group of 20 rich and emerging economies, whose finance officials will meet in Washington later this week.

U.S. President Barack Obama stressed the need for coordinated G20 action to prop up global growth, a White House spokesman said.

(Reporting by Kevin Yao; Writing by Emily Kaiser; Editing by Vidya Ranganathan)

Source: http://us.rd.yahoo.com/dailynews/rss/china/*http%3A//news.yahoo.com/s/nm/20110922/bs_nm/us_global_economy

dart progeria watch free movies online watch free movies online montreal canadiens montreal canadiens jason aldean